Publisher of Iranian Journals and Conference Proceedings

Please waite ..
Publisher of Iranian Journals and Conference Proceedings
Login |Register |Help |عضویت کتابخانه ها
Paper
Title

Immunization against Leishmania major infection in BALB/c mice using a subunit-based DNA vaccine derived from TSA, LmSTI1, KMP11, and LACK predominant antigens

Year: 1398
COI: JR_IJBMS-22-12_017
Language: EnglishView: 219
This Paper With 9 Page And PDF Format Ready To Download

Buy and Download

با استفاده از پرداخت اینترنتی بسیار سریع و ساده می توانید اصل این Paper را که دارای 9 صفحه است به صورت فایل PDF در اختیار داشته باشید.
آدرس ایمیل خود را در کادر زیر وارد نمایید:

Authors

Vahid Jajarmi - Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran|Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences, Tehran,
Ghodratollah Salehi Sangani - Department of Medical Parasitology and Mycology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran|Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran,
Mehdi Mohebali - Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran|Center for Research of Endemic Parasites of Iran (CREPI), Tehran University of Medical Sciences, Tehran, Iran
Ali Khamesipour - Centre for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran

Abstract:

Objective(s): To design a multivalent DNA vaccine encoding the most immunogenic regions of the Leishmania major antigens including TSA (Thiol-specific antioxidant protein), LmSTI1 (Leishmania major stress-inducible protein1), LACK (Leishmania homologue of receptors for activated C Kinase), and KMP11 (kinetoplastid membrane protein-11) on BALB/c mice.Materials and Methods: The chimeric construct was generated including the most immunogenic epitopes containing a combination of domains and oligopeptides of the aforementioned genes. The construct was cloned into pcDNA 3.1 plasmid and named pleish-dom. Following intramuscular injection of mice, the capability of the vector pleish-dom alone and with pIL-12 (expressing murine IL-12) to raise protective cytokines and parasite burden was evaluated in the BALB/c mice as a susceptible animal model against L. major.Results: The immunized mice with pleish-dom/pIL-12 showed the highest and the lowest levels of interferon-gamma (IFN-γ) and interleukin-10 (IL-10), as well as the lowest leishmanin skin test (LST) reactions, were found through 8 weeks post-infection.Conclusion: Although the obtained DNA vaccine from the immunogenic chimeric protein of L. major antigens was able to induce a high level of IFN-γ, it partially protected mice against L. major. However co-administration with pIL-12 led to shift immune response to Th1 phenotype, granuloma formation, and lowered parasite burden, and consequently distinct protection was found.

Keywords:

Paper COI Code

This Paper COI Code is JR_IJBMS-22-12_017. Also You can use the following address to link to this article. This link is permanent and is used as an article registration confirmation in the Civilica reference:

https://civilica.com/doc/959894/

How to Cite to This Paper:

If you want to refer to this Paper in your research work, you can simply use the following phrase in the resources section:
Jajarmi, Vahid and Salehi Sangani, Ghodratollah and Mohebali, Mehdi and Khamesipour, Ali,1398,Immunization against Leishmania major infection in BALB/c mice using a subunit-based DNA vaccine derived from TSA, LmSTI1, KMP11, and LACK predominant antigens,https://civilica.com/doc/959894

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :

  • O mondiale de la Santé, World Health Organization. Leishmaniasis in ...
  • Leishmaniases WECotCot, Meeting WECotCotL, World Health Organization. Control of the ...
  • Khanjani N, González U, Leonardi‐Bee J, Mohebali M, Saffari M, ...
  • Nadim A,Javadian E, Mohebali M. The experience of leishmanization in ...
  • Mohebali M, Khamesipour A, Mobedi I, Zarei Z, Hashemi-Fesharki R. ...
  • Bogdan C, Schröppel K, Lohoff M, Röllinghoff M, Solbach W. ...
  • Ramírez L, Iborra S, Cortés J, Bonay P, Alonso C, ...
  • Dey R, Dagur PK, Selvapandiyan A, McCoy JP, Salotra P, ...
  • Fiuza JA, Dey R, Davenport D, Abdeladhim M, Meneses C, ...
  • Coler RN, Goto Y, Bogatzki L, Raman V, Reed SG. ...
  • Gillespie PM, Beaumier CM, Strych U, Hayward T, Hotez PJ, ...
  • Ahmed SBH, Touihri L, Chtourou Y, Dellagi K, Bahloul C. ...
  • Leitner WW, Thalhamer J. DNA vaccines for non-infectious diseases: new ...
  • Nogueira F, Moreira M, Borja-Cabrera G, Santos F, Menz I, ...
  • Regina-Silva S, Feres AM, França-Silva JC, Dias ES, Michalsky ÉM, ...
  • Moreno J, Vouldoukis I, Martin V, McGahie D, Cuisinier A-M, ...
  • Gupta A, Chaphalkar SR. Current approaches and problems in malaria ...
  • Costa CHN, Peters NC, Maruyama SR, de Brito Jr EC, ...
  • Ramos I, Alonso A, Marcen J, Peris A, Castillo J, ...
  • Campos-Neto A, Webb J, Greeson K, Coler R, Skeiky Y, ...
  • Shahbazi M, Zahedifard F, Taheri T, Taslimi Y, Jamshidi S, ...
  • Rodríguez-Cortés A, Ojeda A, López-Fuertes L, Timón M, Altet L, ...
  • Kedzierski L. Leishmaniasis vaccine: where are we today J Glob ...
  • Sette A, Fikes J. Epitope-based vaccines: an update on epitope ...
  • Ivory C, Chadee K. DNA vaccines: designing strategies against parasitic ...
  • Saade F, Petrovsky N. Technologies for enhanced efficacy of DNA ...
  • Okwor I, Uzonna JE. Pathways leading to interleukin-12 production and ...
  • Seyed N, Zahedifard F, Safaiyan S, Gholami E, Doustdari F, ...
  • Agallou M, Athanasiou E, Koutsoni O, Dotsika E, Karagouni E. Experimental validation ...
  • Das S, Freier A, Boussoffara T, Das S, Oswald D, ...
  • Matos  I, Mizenina O, Lubkin A, Steinman RM, Idoyaga J. Targeting ...
  • Jensen K.D, Sercarz EE, Gabaglia CR. Altered peptide ligands can ...
  • Azizi H, Kazemi B, Bandehpour M, Mohebali M, Khamesipour A, ...
  • Yadegari Z, Bandehpour M, Kazemi B, Sharifi-Sarasiabi K. Expression of ...
  • Buffet P, Sulahian A, Garin Y, Nassar N, Derouin F. ...
  • Stauber LA. Host resistance to the Khartoum strain of Leishmania ...
  • Shirzadi M, Esfahania S, Mohebalia M, Ershadia M, Gharachorlo F, ...
  • Salehi Gh, Fata A, Mohaghegh MA, Mousavi Bazzaz SM, Rafatpanah ...
  • Handman E. Leishmaniasis: current status of vaccine development. Clin Microbiol ...
  • Desjeux, P., Leishmaniasis: current situation and new perspectives. Comp Immunol ...
  • Von Stebut E, Tenzer S. Cutaneous leishmaniasis: Distinct functions of ...
  • Maspi N, Ghaffarifar F, Sharifi Z, Dalimi A, Dayer MS. ...
  • Coler RN, Reed SG. Second-generation vaccines against leishmaniasis. Trends Parasitol ...
  • Skeiky YA, Coler RN, Brannon M, Stromberg E, Greeson K, ...
  • Martínez‐López M, Iborra S, Conde‐Garrosa R, Sancho D. Batf3‐dependent CD103+ ...
  • Darrah PA, Patel DT, De Luca PM, Lindsay R, Davey ...
  • Teng MW, Bowman EP, McElwee JJ, Smyth MJ, Casanova J-L, ...
  • Bhaumik S, Basu R, Sen S, Naskar K, Roy S. ...
  • Heinemann C, Heink S, Petermann F, Vasanthakumar A, Rothhammer V, ...
  • Cavalcanti AS, Ribeiro-Alves M, de OR Pereira L, Mestre GL, ...
  • Abdoli A, Maspi N, Ghaffarifar F. Wound healing in cutaneous ...
  • ScottP, Novais FO. Cutaneous leishmaniasis: immune responses in protection and ...

Research Info Management

Certificate | Report | من نویسنده این مقاله هستم

اطلاعات استنادی این Paper را به نرم افزارهای مدیریت اطلاعات علمی و استنادی ارسال نمایید و در تحقیقات خود از آن استفاده نمایید.

Scientometrics

The specifications of the publisher center of this Paper are as follows:
Type of center: علوم پزشکی
Paper count: 5,527
In the scientometrics section of CIVILICA, you can see the scientific ranking of the Iranian academic and research centers based on the statistics of indexed articles.

Share this page

More information about COI

COI stands for "CIVILICA Object Identifier". COI is the unique code assigned to articles of Iranian conferences and journals when indexing on the CIVILICA citation database.

The COI is the national code of documents indexed in CIVILICA and is a unique and permanent code. it can always be cited and tracked and assumed as registration confirmation ID.

Support